CN Bio

CN Bio is a pioneer in developing organ-on-a-chip platforms, capable of discovering better and safer treatments for serious human diseases. Our strength comes from having almost unparalleled resources to invest in the development of leading organ chips, thanks to over $32 million in grants and contracts from DARPA, NIH, EU FP7, Innovate UK, and NC3Rs.